Extended Data Fig. 5: In vivo behavior of circulating tumor-reactive T cells -Arm B.
From: Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial
Trends and profile of circulating T cells specific for both targeted (left side) and non-targeted (right side) TAAs in each individual patient treated in arm B. Results are reported as SFC/2×105 at each specified time point.
